Skip to main
EDAP
EDAP logo

EDAP TMS (EDAP) Stock Forecast & Price Target

EDAP TMS (EDAP) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 50%
Buy 17%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Edap TMS has recorded a significant 63% year-over-year increase in procedure volume within its HIFU division, reflecting strong market adoption among urologists and enhancing revenue contribution from disposable products. The company is poised for future growth due to recent developments, including the favorable presentation of HIFI study results at major annual meetings and the attainment of reimbursement approval in Switzerland, which enhances its commercial presence in Europe and the Middle East. Additionally, the positive outcomes reported in clinical studies—such as reductions in pelvic pain scores and endometriosis nodule volumes—bolster the long-term potential for HIFU technology, further supporting the company's growth trajectory.

Bears say

Edap TMS SA reported a decline in HIFU-related revenue, reaching €4.8 million in the second quarter of 2024, down from €4.9 million in the same quarter of the previous year, which can be attributed to unrealized revenues from system placements. Additionally, the interim results of a study concerning the use of HIFU treatment for endometriosis fell short of the primary endpoint of reducing acute pelvic pain, raising concerns about the therapy's effectiveness and potential market acceptance. Collectively, these factors suggest underlying challenges within the HIFU division that may negatively impact Edap TMS's overall financial performance and growth prospects.

EDAP TMS (EDAP) has been analyzed by 6 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 17% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of EDAP TMS and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About EDAP TMS (EDAP) Forecast

Analysts have given EDAP TMS (EDAP) a Buy based on their latest research and market trends.

According to 6 analysts, EDAP TMS (EDAP) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

EDAP TMS (EDAP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.